Results 101 to 110 of about 3,152,535 (345)

Does competition enhance performance or cheating? A laboratory experiment [PDF]

In this paper we experimentally test whether competing for a desired reward does not only affect individuals’ performance, but also their tendency to cheat. Recent doping scandals in sports as well as forgery and plagiarism scandals in academia have been
Christiane Schwieren, Doris Weichselbaumer   +1 more
core   +3 more sources

Simulation of Coherent Beam Propagation in Laboratory and Numerical Experiments: A Comparison of Results

Photonics
This paper presents the results of processing and systematizing data from laboratory and numerical experiments to correct the distortions of laser radiation propagating through a randomly inhomogeneous medium.
Feodor Kanev, Alexey Rukosuev, Ilya Galaktionov, Julia Sheldakova, Igor Veretekhin   +4 more
doaj   +1 more source

How Dynamic Boundary Conditions Induce Solute Trapping and Quasi‐stagnant Zones in Laboratory Experiments Comprising Unsaturated Heterogeneous Porous Media [PDF]

, 2019
Clemens Cremer, Insa Neuweiler
openalex   +1 more source

Zero-gravity cloud physics laboratory: Experiment program definition and preliminary laboratory concept studies [PDF]

The experiment program definition and preliminary laboratory concept studies on the zero G cloud physics laboratory are reported. This program involves the definition and development of an atmospheric cloud physics laboratory and the selection and ...
Eaton, L. R., Greco, E. V.
core   +1 more source

Vertex reconstruction algorithms in the PHOBOS experiment at RHIC

, 2006
The PHOBOS experiment at the Relativistic Heavy Ion Collider (RHIC) at Brookhaven National Laboratory is studying interactions of heavy nuclei at the largest energies available in the laboratory.
E. García, M. P. Decowski, Phobos Collaboration, T. Gburek, V. Chetluru   +4 more
core   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Sorting into Physician Payment Schemes – A Laboratory Experiment [PDF]

, 2014
Jeannette Brosig‐Koch, Nadja Kairies‐Schwarz, Johanna Kokot   +2 more
openalex   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Laboratory experiments of particle size effect in X-ray fluorescence and implications to remote X-ray spectrometry of lunar regolith surface [PDF]

, 2008
Yoko Maruyama, Kazunori Ogawa, Tatsuaki Okada, Manabu Kato   +3 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source